Guildford, UK, 10th September 2018 – IDBS, a leader in enterprise scientific informatics platforms, today announced that Christian Marcazzo has joined the company as Vice President and General Manager, effective immediately.
Christian will be responsible for running IDBS and growing the Informatics Solutions business of the Danaher Life Sciences Platform.
Christian will have P&L responsibility, including establishing the business strategy, identifying future growth by evaluating organic and inorganic opportunities, driving flawless execution of the sales and professional service strategies, executing the new product roadmap, and attracting and developing a winning team.
“I’m pleased to be joining the talented and dedicated team at IDBS,” said Christian.
“IDBS technology is the backbone for many organizations’ R&D efforts, enabling them to capture, manage and report on critical research data. I believe the combination of IDBS’ expertise in enterprise scientific informatics platforms and Danaher’s business systems and global reach will be a driver of long-term growth and innovation for our customers.”
“We sit at a time of extraordinary change – the growth of new personalized and biological therapies, the changing landscape of healthcare in all markets, the increasing externalization of R&D work, and the rise of the cloud are all forces of transformation and innovation across the life sciences market. IDBS has been a leader in collaborating with customers to address these changes, and I believe we are well positioned to continue to do so.”
Joining IDBS from PerkinElmer Informatics, where he was VP Analytics & Search, Christian has worked for companies including TIBCO, Spotfire and LION bioscience in the UK, US, and Germany. He has held senior global roles in sales, marketing and product management.
Christian has a BA in Molecular and Cell Biology from the University of California, Berkeley. He will be based at the IDBS headquarters in Guildford, UK.
IDBS became part of Danaher Corporation’s Life Sciences platform in late 2017, joining businesses such as SCIEX, Phenomenex, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices.